ACC 2017: Late-Breaking Clinical Trials
Research includes safety of digoxin with atrial fibrillation, comparison of cerebral embolic protection devices, and cerebral microbleed triggers.
ACC 2017: CV Risk Factors
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
ACTRIMS 2017 Forum: MS Treatment Clinical Trials
Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.
ISC 2017: Vascular Cognitive Impairment
Research included the impact of diet on cognitive decline and the degree of a link between depression & dementia post intracerebral hemorrhage.
Interesting Neuro: Stroke Risks & Treatment
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
Interesting Neuro: Epilepsy Outcomes & Vitamin D
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.
Top 10: Neurology Times 2016
From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.
Impact of Epilepsy on Other Neurological Disorders
Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.
Interesting Neuro: Tau Vaccine & Winter Zika Risk
November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.
By clicking Accept, you agree to become a member of the UBM Medica Community.